Summary & Overview
CPT 0601T: Open Irreversible Electroporation Tumor Ablation
CPT code 0601T denotes an open surgical irreversible electroporation (IRE) ablation procedure in which probes are inserted directly into tumor tissue and high‑intensity, microsecond electrical pulses are delivered to permeabilize and destroy tumor cell membranes. The procedure includes imaging guidance and can treat one or more tumors in a single organ. Nationally, the code represents a specialized, device‑driven ablative oncology service used for tumors that may be unsuitable for thermal ablation or resection.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a focused overview of the clinical service, typical sites of care, and payer relevance. The publication summarizes available benchmarks where present, highlights coding and billing considerations tied to an open operative approach with integrated imaging guidance, and places the service in clinical context as a nonthermal tumor ablation option.
This resource is intended to inform revenue cycle, clinical coding, and policy teams about the clinical nature of the service, typical delivery settings, and the payers most likely to be involved in coverage and reimbursement decisions. Data not available in the input where applicable.
Billing Code Overview
CPT code 0601T describes an irreversible electroporation ablation procedure performed via an open surgical approach. The provider inserts one or more probes directly into the tumor site and delivers very short (microsecond), high‑intensity, nonthermal electrical pulses that permeabilize cell membranes to destroy tumor cells and prevent cell division. The service includes imaging guidance as part of the procedure and is intended to treat one or more tumors within a single organ.
Service Type: Open surgical irreversible electroporation ablation
Typical Site of Service: Operating room / inpatient or outpatient surgical facility
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with one or more unresectable focal tumors in a solid organ (commonly liver, pancreas, kidney, or prostate) who is referred for open irreversible electroporation (IRE) ablation. The patient often has prior imaging (CT or MRI) demonstrating a target lesion(s) not amenable to surgical resection due to proximity to vital structures or underlying comorbidity. Preoperative evaluation includes cross-sectional imaging review, laboratory assessment (including coagulation profile and hepatic/renal function as applicable), and anesthesia assessment for an open procedure under general anesthesia.
Intraoperative workflow: the patient undergoes an open laparotomy or thoracotomy to expose the organ. The surgeon inserts one or more IRE probes into and around the tumor under direct visualization and intraoperative imaging; imaging guidance is included in the procedure and is not reported separately. Short-duration, high-voltage electrical pulses are delivered to create irreversible permeabilization of tumor cell membranes. The provider treats one or more tumors per organ during the same operative episode. Hemostasis is confirmed, and the incision is closed. Postoperative care includes monitoring for organ-specific complications, pain control, and follow-up imaging to assess ablation completeness and detect recurrence.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work, time, or intensity substantially exceeds usual for and documentation supports additional payment. |